These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 614237)

  • 1. Genetics of Parkinson's disease: biochemical epidemiologic and neuropathologic correlations.
    Ambani LM
    Indian J Med Sci; 1977 Feb; 31(2):21-9. PubMed ID: 614237
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease. A genetic study.
    Martin WE; Young WI; Anderson VE
    Brain; 1973 Sep; 96(3):495-506. PubMed ID: 4147573
    [No Abstract]   [Full Text] [Related]  

  • 3. [A little bit of PINK in Parkinson's disease].
    Berthier A
    Med Sci (Paris); 2008 Feb; 24(2):118-9. PubMed ID: 18272063
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical pathophysiology of Parkinson's disease.
    Hornykiewicz O; Kish SJ
    Adv Neurol; 1987; 45():19-34. PubMed ID: 2881444
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain glutamic acid decarboxylase activity in Parkinson's disease.
    Rinne UK; Laaksonen H; Riekkinen P; Sonninen V
    Eur Neurol; 1974; 12(1):13-9. PubMed ID: 4412241
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain acetylcholinesterase in Parkinson's disease.
    Rinne UK; Riekkinen P; Sonninen V; Laaksonen H
    Acta Neurol Scand; 1973; 49(2):215-26. PubMed ID: 4718190
    [No Abstract]   [Full Text] [Related]  

  • 7. The genetics of Parkinson's disease. A review.
    Duvoisin RC
    Adv Neurol; 1993; 60():306-15. PubMed ID: 8420146
    [No Abstract]   [Full Text] [Related]  

  • 8. Glutathion S-transferase (class mu) phenotype in Parkinson's disease.
    Tison F; Coutelle C; Henry P; Cassaigne A
    Mov Disord; 1994 Jan; 9(1):117-8. PubMed ID: 8139597
    [No Abstract]   [Full Text] [Related]  

  • 9. Brain proteasomal function in sporadic Parkinson's disease and related disorders.
    Furukawa Y; Vigouroux S; Wong H; Guttman M; Rajput AH; Ang L; Briand M; Kish SJ; Briand Y
    Ann Neurol; 2002 Jun; 51(6):779-82. PubMed ID: 12112087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
    Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
    Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q.
    Mori H; Kondo T; Yokochi M; Matsumine H; Nakagawa-Hattori Y; Miyake T; Suda K; Mizuno Y
    Neurology; 1998 Sep; 51(3):890-2. PubMed ID: 9748052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No increase of synthesis of (R)salsolinol in Parkinson's disease.
    Müller T; Przuntek H; Kuhn W; Baum SS; Rommelspacher H
    Mov Disord; 1999 May; 14(3):514-5. PubMed ID: 10348481
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxins, genetics, and Parkinson's disease: the role of N-acetyltransferase 2.
    Bandmann O; Vaughan J; Holmans PA; Marsden CD; Wood NW
    Adv Neurol; 1999; 80():199-204. PubMed ID: 10410722
    [No Abstract]   [Full Text] [Related]  

  • 14. Superoxide dismutase expression in Parkinson's disease.
    Poirier J; Dea D; Baccichet A; Thiffault C
    Ann N Y Acad Sci; 1994 Nov; 738():116-20. PubMed ID: 7832421
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathogenesis of Parkinson's disease through LRRK2 mutation].
    Ohta E; Obata F
    Seikagaku; 2014 Feb; 86(1):92-7. PubMed ID: 24693706
    [No Abstract]   [Full Text] [Related]  

  • 16. Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease.
    Ogawa K; Yamada T; Tsujioka Y; Taguchi J; Takahashi M; Tsuboi Y; Fujino Y; Nakajima M; Yamamoto T; Akatsu H; Mitsui S; Yamaguchi N
    Psychiatry Clin Neurosci; 2000 Aug; 54(4):419-26. PubMed ID: 10997858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients.
    Mann A; Miksys SL; Gaedigk A; Kish SJ; Mash DC; Tyndale RF
    Neurobiol Aging; 2012 Sep; 33(9):2160-71. PubMed ID: 21958961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease susceptibility variants and severity of Lewy body pathology.
    Heckman MG; Kasanuki K; Diehl NN; Koga S; Soto A; Murray ME; Dickson DW; Ross OA
    Parkinsonism Relat Disord; 2017 Nov; 44():79-84. PubMed ID: 28917824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component.
    Perez-Pastene C; Graumann R; Díaz-Grez F; Miranda M; Venegas P; Godoy OT; Layson L; Villagra R; Matamala JM; Herrera L; Segura-Aguilar J
    Neurosci Lett; 2007 May; 418(2):181-5. PubMed ID: 17403576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic enzyme systems in Parkinson's disease.
    McGeer PL; McGeer EG
    Arch Neurol; 1971 Sep; 25(3):265-8. PubMed ID: 4157296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.